Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis. Ann Neurol 1995 Apr;37(4):546-9
Date
04/01/1995Pubmed ID
7717692DOI
10.1002/ana.410370418Scopus ID
2-s2.0-0028987125 17 CitationsAbstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that has been postulated to be T-cell mediated. We examined the proliferation and cytokine secretion of mononuclear cells after stimulation with OKT3 (anti-CD3) monoclonal antibody concanavalin A, or ionomycin plus myristic acid palmityl ester in subjects with stable relapsing-remitting MS. Control subjects demonstrated good proliferation to anti-CD3 monoclonal antibody whereas subjects with relapsing-remitting MS showed a significantly decreased anti-CD3 monoclonal antibody-mediated response. There was no difference in concanavalin or ionomycin plus myristic acid palmityl ester stimulation between control subjects and MS subjects. Secretion of interferon-gamma was significantly decreased and transforming growth factor-beta was significantly increased from cultures stimulated with anti-CD3 monoclonal antibody, but not ionomycin plus myristic acid palmityl ester or concanavalin A, in MS patients compared to control subjects. Secretion of interleukin-10 and tumor necrosis factor-alpha was not different between control subjects and MS patients following stimulation with anti-CD3 monoclonal antibody, concanavalin A, or ionomycin plus myristic acid palmityl ester, or of interleukin-2 and interleukin-4 following stimulation with anti-CD3 monoclonal antibody or concanavalin A. An abnormality of signal transduction and secretion of the immunomodulatory molecule interferon-gamma may exist in MS via the CD3 T-cell receptor complex.
Author List
Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JSAuthor
Staley A. Brod MD Professor in the Neurology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
CD3 ComplexCytokines
Enzyme-Linked Immunosorbent Assay
Humans
Interferon-gamma
Multiple Sclerosis